SciMed Solutions Releases Scalable Adjuvant Discovery Software

DURHAM, N.C., April 9, 2020 /PRNewswire/ — SciMed Solutions today announced the release of Compound Scout, a high-throughput adjuvant screening software initially developed for use by the Duke Human Vaccine Institute (DHVI). Compound Scout is now available for use by small to mid-sized labs and primary researchers in a scalable software as a service (SaaS) model.

“We continually face novel and mutating viruses and bacteria that require the development of new vaccines and pharmaceuticals,” says Adam Stasio, president of SciMed Solutions. “Storing, managing, and analyzing high-throughput screening data efficiently and effectively has been out of reach for many primary researchers and smaller, independent labs. We are offering Compound Scout in a scalable SaaS version that makes it affordable for researchers, enabling them to accurately increase their testing speed and help new vaccines and medications get to market more quickly.” Compound Scout was developed to increase testing capacity for adjuvant and drug screening, biopharmaceutical development, and vaccine research.

About SciMed Solutions

SciMed Solutions builds innovative software products and provides consulting services to streamline workflows and increase efficiency so researchers can focus on your core mission. Located in downtown Durham, North Carolina, SciMed has been developing software since 2003. Learn more about SciMed Solutions at www.scimedsolutions.com or visit the Compound Scout website at www.compoundscout.com.

 

View original content:http://www.prnewswire.com/news-releases/scimed-solutions-releases-scalable-adjuvant-discovery-software-301038493.html

SOURCE SciMed Solutions

Staff

Recent Posts

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…

27 minutes ago

Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship

The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…

3 hours ago

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…

3 hours ago

KLAS Report Shows Strong Early Results for TrustCommerce Cloud Payments

CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…

3 hours ago

BioFlorida Announces Appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of the Southeast Chapter

MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…

3 hours ago

Truemed Closes $34 Million Series A To Unlock HSA/FSA Funds For Lifestyle Interventions

Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…

3 hours ago